Physician profile
Steven Sprankle
NPI 1801043146
$2,481.76
in general payments reported to CMS, 2019-2025
16 companies · $252 in 2025
The $252 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,046 · 2020: $252 · 2021: $364 · 2022: $345 · 2023: $106 · 2024: $116 · 2025: $252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $474.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $474.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $631.78 | 2019-2025 | Lifevest |
| Abbott Laboratories | $303.44 | 2019-2025 | Gallant, Agilis Hispro, Allure Quadra |
| Janssen Pharmaceuticals, INC | $292.51 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $262.55 | 2019-2025 | Eliquis, Camzyos |
| Novartis Pharmaceuticals Corporation | $228.34 | 2019 | |
| Amgen INC. | $175.14 | 2019-2022 | |
| Pfizer INC. | $168.67 | 2019-2020 | |
| Abiomed | $138.25 | 2021-2023 | Impella |
| Actelion Pharmaceuticals US, INC. | $125.00 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.46 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $23.39 | 2019 | |
| Novo Nordisk INC | $20.78 | 2019 | |
| Amarin Pharma, INC. | $20.58 | 2020 | |
| Ge Healthcare | $16.04 | 2019 | |
| Terumo Medical Corporation | $15.99 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $14.84 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Sprankle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.